InventionMed S.A. (WSE:INM)
0.1610
+0.0025 (1.58%)
At close: Sep 12, 2025
InventionMed Revenue
InventionMed had revenue of 1.58M PLN in the quarter ending June 30, 2025, with 3,285.41% growth. This brings the company's revenue in the last twelve months to 2.01M, up 4,182.88% year-over-year. In the year 2024, InventionMed had annual revenue of 277.76K with 45,810.74% growth.
Revenue (ttm)
2.01M
Revenue Growth
+4,182.88%
P/S Ratio
16.27
Revenue / Employee
401.39K
Employees
5
Market Cap
32.65M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 277.76K | 277.16K | 45,810.74% |
Dec 31, 2023 | 605.00 | -3.46K | -85.12% |
Dec 31, 2022 | 4.07K | -6.39K | -61.10% |
Dec 31, 2021 | 10.45K | 5.25K | 100.96% |
Dec 31, 2020 | 5.20K | -35.80K | -87.32% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Diagnostyka | 2.17B |
NEUCA | 13.04B |
Synektik Spólka Akcyjna | 623.20M |
Voxel | 560.38M |
Celon Pharma | 215.11M |
Ryvu Therapeutics | 97.57M |
Selvita | 359.79M |
Centrum Medyczne ENEL-MED | 762.83M |